Our Pricing

Weight Loss Injections Online UK: Complete Prescriber Guide

Accessing weight loss injections online UK has never been simpler with Cured Pharmacy's transparent service. Our UK-registered clinical team offers free consultations under 3 minutes, with genuine MHRA-licensed treatments including Mounjaro, Wegovy, and Saxenda delivered discreetly to your door.

How Weight Loss Injections Work in Your Body

Weight loss injections belong to a class of medications called GLP-1 receptor agonists, which mimic natural hormones that regulate appetite and blood sugar levels [1]. These treatments work by slowing gastric emptying, reducing hunger signals to the brain, and improving insulin sensitivity — creating a multi-pathway approach to sustainable weight reduction.

Clinical trials demonstrate significant efficacy across different formulations. Tirzepatide (Mounjaro) acts on both GIP and GLP-1 receptors, producing average weight reductions of 20.9% over 72 weeks in the SURMOUNT-1 trial [2]. Semaglutide-based treatments like Wegovy showed mean reductions of 14.9% in the STEP-1 trial [3], whilst liraglutide (Saxenda) achieved 8% average weight loss over 56 weeks [4].

These medications are prescription-only in the UK and require clinical assessment by a registered prescriber to ensure suitability, appropriate dosing, and safe monitoring throughout your treatment journey.

Mounjaro: The Dual-Action Weight Loss Injection

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management [2]. This dual mechanism provides enhanced metabolic effects compared to single-pathway alternatives, targeting both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors simultaneously.

Available from £135.00 at Cured Pharmacy, Mounjaro is administered once weekly using a pre-filled KwikPen device. Treatment begins at 2.5mg for four weeks, then increases gradually to minimise gastrointestinal side effects — a titration schedule designed to optimise tolerance whilst building therapeutic effect [2].

The SURPASS clinical programme demonstrated superior weight reduction with tirzepatide compared to semaglutide 1mg, with participants on the 15mg maintenance dose achieving up to 22.5% body weight reduction [2]. All Mounjaro prescriptions at Cured Pharmacy require completion of a clinical assessment by our UK-registered prescribers, who evaluate your medical history, current medications, and weight management goals.

Who Can Use Mounjaro Safely

Mounjaro is licensed for adults with a BMI of 30 kg/m² or above, or 27 kg/m² with at least one weight-related comorbidity such as hypertension or type 2 diabetes [2]. Your prescriber will assess contraindications including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease.

Common side effects include nausea, diarrhoea, and reduced appetite — typically mild to moderate and diminishing as your body adjusts to treatment [2]. Our clinical team provides guidance on managing these effects and determining when dose escalation is appropriate based on your individual tolerance and response.

Wegovy and Saxenda: Semaglutide and Liraglutide Options

Wegovy contains semaglutide, a GLP-1 receptor agonist administered once weekly via subcutaneous injection. In the STEP trials, participants achieved average weight loss of 14.9% over 68 weeks when combined with lifestyle modifications [3]. Wegovy is priced competitively at Cured Pharmacy, with transparent costs displayed before your consultation begins.

Saxenda offers an alternative formulation using liraglutide, administered daily rather than weekly. Whilst requiring more frequent injections, Saxenda provides flexibility for patients who prefer gradual dose adjustments or have concerns about longer-acting formulations [4]. Clinical trials showed mean weight reductions of 8% over 56 weeks in patients without diabetes [4].

Both treatments require prescription authorisation following clinical assessment. Our UK prescribers evaluate which formulation aligns with your medical profile, lifestyle preferences, and treatment goals — considering factors like injection frequency tolerance, previous medication responses, and concurrent health conditions.

Choosing Between Weekly and Daily Injections

Weekly injections like Wegovy and Mounjaro offer convenience and sustained therapeutic levels with fewer administration occasions, potentially improving long-term adherence [3]. Daily injections like Saxenda allow more precise dose titration and faster adjustment if side effects occur, which some patients find reassuring during initial treatment phases.

Your prescriber will discuss these practical considerations alongside clinical factors to determine the most appropriate option. All weight loss injections available through Cured Pharmacy are genuine UK-licensed medications dispensed by our GPhC-registered pharmacy (9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

Orlistat and Oral Weight Management Alternatives

For patients seeking non-injectable options, orlistat offers a different mechanism of action by inhibiting pancreatic lipase enzymes, reducing dietary fat absorption by approximately 30% [5]. Available as prescription-strength Xenical (120mg) or lower-dose over-the-counter formulations like Alli (60mg) and Orlos, orlistat is taken three times daily with meals containing fat.

Clinical trials demonstrate average weight loss of 2.9kg more than diet alone over 12 months with orlistat 120mg [5]. Whilst less dramatic than injectable GLP-1 treatments, orlistat suits patients with contraindications to injections or those preferring oral medication. Common side effects relate to unabsorbed fat and include oily stools, increased bowel movements, and flatulence — effects minimised by adhering to a reduced-fat diet.

Cured Pharmacy also offers pre-orders for Wegovy® oral tablets (semaglutide pill), providing the benefits of semaglutide without injections once this formulation receives full UK market authorisation. This emerging option may appeal to patients seeking GLP-1 efficacy with oral administration convenience.

The Cured Pharmacy Clinical Assessment Process

Every prescription weight loss treatment at Cured Pharmacy begins with a comprehensive online clinical assessment completed in under 3 minutes. Our UK-registered prescribers review your medical history, current medications, allergies, weight management history, and treatment goals to determine the safest and most effective option for your individual circumstances.

Unlike services that hide pricing until after consultation, Cured Pharmacy displays transparent upfront costs for all treatments. You'll see exactly what you'll pay before completing your assessment — no hidden fees, no surprise charges, just honest pricing backed by our Lowest Prices Guaranteed commitment across the UK.

Once your prescriber approves treatment, your medication is dispensed by our GPhC-registered pharmacy and dispatched in 100% discreet packaging. We source only genuine UK-licensed medicines from authorised wholesalers, ensuring you receive the same quality medications available through traditional high-street pharmacies. Ongoing support is available via phone (+44 116 4646009) or through your online account, with prescribers accessible for dose adjustments, side effect management, or treatment reviews.

What Your Prescriber Evaluates

Clinical assessment covers your current BMI, weight loss goals, previous treatment attempts, relevant medical conditions (cardiovascular disease, pancreatitis history, thyroid disorders), current medications that may interact, and psychological readiness for long-term weight management. Your prescriber may request additional information or suggest alternative treatments if initial preferences aren't clinically appropriate.

This thorough evaluation ensures treatment safety and optimises outcomes. Weight loss medications work best when combined with dietary modifications and increased physical activity — your prescriber will discuss realistic expectations and sustainable lifestyle changes to support your pharmaceutical intervention.

Maximising Results with Weight Loss Injections

Clinical trial results reflect participants who combined medication with reduced-calorie diets and increased physical activity [2][3][4]. To achieve comparable outcomes, focus on creating a sustainable calorie deficit through portion control, nutrient-dense food choices, and regular movement that fits your current fitness level and daily routine.

Weight loss injections reduce appetite and cravings, making dietary adherence significantly easier than willpower alone. Use this pharmacological support to establish healthier eating patterns — prioritising protein intake to preserve muscle mass, consuming adequate fibre for satiety and digestive health, and staying well-hydrated throughout treatment.

Expect gradual, steady weight reduction rather than rapid drops. Most patients notice appetite suppression within the first week, with measurable weight loss emerging over subsequent weeks as dose escalates. Your prescriber will monitor progress and adjust treatment as needed, potentially switching formulations if response is suboptimal or side effects prove intolerable. Realistic expectations and patience are essential — sustainable weight management is a marathon, not a sprint, and these medications provide powerful tools to support your long-term success.

Managing Side Effects Effectively

Gastrointestinal side effects are most common during initial weeks and dose increases [2][3][4]. Minimise nausea by eating smaller, more frequent meals, avoiding high-fat and spicy foods, and taking injections at consistent times. If side effects persist or worsen, contact your prescriber — dose adjustments or slower titration schedules often resolve tolerance issues without discontinuing treatment.

Injection site reactions (redness, itching, minor swelling) typically resolve within days. Rotate injection sites between abdomen, thigh, and upper arm to prevent localised irritation. Ensure pens are at room temperature before injecting and use proper technique as demonstrated in the patient information leaflet included with your medication.

Scientific References

1. Nauck, M. A., Quast, D. R., Wefers, J., & Meier, J. J. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. https://doi.org/10.1016/j.molmet.2020.101102
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–218. https://doi.org/10.1056/NEJMoa2206038
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary and are not guaranteed.